NASH – January 2021 NASH – January 2021 FDA cleared IND for TERN-501 Phase 1 trial for the treatment of NASH 19 Jan 2021 Terns Pharmaceuticals – TERN-501 (THR-β agonist, Phase 1); TERN-101 (FXR agonist, Phase 2a) TERN-501 will be […]
Contact:
info@ciscientists.com
+1-908-212-7484
Optimal Dose
For a subscription, please provide your email id